Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approach

Journal of pharmaceutical policy and practice, 2023-07, Vol.16 (1), p.84-84, Article 84 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 2052-3211 ;EISSN: 2052-3211 ;DOI: 10.1186/s40545-023-00590-9 ;PMID: 37408046

Full text available